176 related articles for article (PubMed ID: 8415709)
1. JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2.
Kameda T; Akahori A; Sonobe MH; Suzuki T; Endo T; Iba H
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9369-73. PubMed ID: 8415709
[TBL] [Abstract][Full Text] [Related]
2. Analysis of AP-1 function in cellular transformation pathways.
Suzuki T; Murakami M; Onai N; Fukuda E; Hashimoto Y; Sonobe MH; Kameda T; Ichinose M; Miki K; Iba H
J Virol; 1994 Jun; 68(6):3527-35. PubMed ID: 8189491
[TBL] [Abstract][Full Text] [Related]
3. Difference in transcriptional regulatory function between c-Fos and Fra-2.
Suzuki T; Okuno H; Yoshida T; Endo T; Nishina H; Iba H
Nucleic Acids Res; 1991 Oct; 19(20):5537-42. PubMed ID: 1945831
[TBL] [Abstract][Full Text] [Related]
4. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
5. Fos family members: regulation, structure and role in oncogenic transformation.
Tulchinsky E
Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
[TBL] [Abstract][Full Text] [Related]
6. Attenuated expression of the serum responsive T1 gene in ras transformed fibroblasts due to the inhibition of c-fos gene activity.
Kessler R; Zacharova-Albinger A; Laursen NB; Kalousek M; Klemenz R
Oncogene; 1999 Mar; 18(9):1733-44. PubMed ID: 10208434
[TBL] [Abstract][Full Text] [Related]
7. A rearranged junD transforms chicken embryo fibroblasts.
Hartl M; Vogt PK
Cell Growth Differ; 1992 Dec; 3(12):909-18. PubMed ID: 1472471
[TBL] [Abstract][Full Text] [Related]
8. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
Kataoka K; Noda M; Nishizawa M
Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
[TBL] [Abstract][Full Text] [Related]
9. Increased transforming activity of JunB and JunD by introduction of an heterologous homodimerization domain.
Vandel L; Pfarr CM; Huguier S; Loiseau L; Sergeant A; Castellazzi M
Oncogene; 1995 Feb; 10(3):495-507. PubMed ID: 7845674
[TBL] [Abstract][Full Text] [Related]
10. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.
McCabe LR; Banerjee C; Kundu R; Harrison RJ; Dobner PR; Stein JL; Lian JB; Stein GS
Endocrinology; 1996 Oct; 137(10):4398-408. PubMed ID: 8828501
[TBL] [Abstract][Full Text] [Related]
11. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun.
Hughes M; Sehgal A; Hadman M; Bos T
Cell Growth Differ; 1992 Dec; 3(12):889-97. PubMed ID: 1472469
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of fra-2, an additional member of the fos gene family.
Nishina H; Sato H; Suzuki T; Sato M; Iba H
Proc Natl Acad Sci U S A; 1990 May; 87(9):3619-23. PubMed ID: 2110368
[TBL] [Abstract][Full Text] [Related]
13. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
Morgan IM; Asano M; Håvarstein LS; Ishikawa H; Hiiragi T; Ito Y; Vogt PK
Oncogene; 1993 May; 8(5):1135-40. PubMed ID: 8479738
[TBL] [Abstract][Full Text] [Related]
14. In vitro transforming capacities of mouse c-jun:junD chimeric genes.
Métivier C; Piu F; Pfarr CM; Yaniv M; Loiseau L; Castellazzi M
Oncogene; 1993 Aug; 8(8):2311-5. PubMed ID: 8336952
[TBL] [Abstract][Full Text] [Related]
15. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells.
Smart DE; Vincent KJ; Arthur MJ; Eickelberg O; Castellazzi M; Mann J; Mann DA
J Biol Chem; 2001 Jun; 276(26):24414-21. PubMed ID: 11337499
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins.
Rutberg SE; Saez E; Glick A; Dlugosz AA; Spiegelman BM; Yuspa SH
Oncogene; 1996 Jul; 13(1):167-76. PubMed ID: 8700543
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
18. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines.
Rezzonico R; Loubat A; Lallemand D; Pfarr CM; Far DF; Proudfoot A; Rossi B; Ponzio G
Oncogene; 1995 Sep; 11(6):1069-78. PubMed ID: 7566966
[TBL] [Abstract][Full Text] [Related]
20. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
